(Total Views: 301)
Posted On: 05/26/2020 10:38:32 AM
Post# of 36541
Here are those headlines from Dow Jones...
GenerexBiotechnology: Begun to Plan a Trial of Ii-Key-GP100-TYR Peptide Vaccine for Treatment of Melanoma >GNBT
DJ REALTIME NEWS – 9:47 AM ET 05/22/2020
Generex Biotechnology Planning to Initiate Trial of AE37 in Combination With Checkpoint Inhibitor for Immunotherapeutic Treatment of Bladder Cancer >GNBT
DJ REALTIME NEWS – 9:47 AM ET 05/22/2020
Generex Biotechnology Expect Enrollment to Speed Up With Positive Results as Coronavirus Pandemic Subsides >GNBT
(0)
(0)
Scroll down for more posts ▼